Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
批准号:
7763812
负责人:
Joey V. Barnett
金额:
$42.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2012-01-31
关键词:
AccountingAddressAdultAnimalsAppearanceBasic ScienceBiological AssayBlood VesselsCardiovascular DiseasesCell Differentiation processCell LineageCellsCessation of lifeClinicalCoronaryCoronary ArteriosclerosisCoronary VesselsDataDerivation procedureDevelopmentDiseaseDrug Delivery SystemsEmbryoEndothelial CellsEpicardiumEpithelialFailureGenerationsHandHumanImmune SeraIn VitroLaboratoriesLacZ GenesLeftModelingMusMyocardialMyocardiumNatureNull LymphocytesPathway interactionsPublished CommentRegulationReportingResearch PersonnelRoleSignal PathwaySignal TransductionSmooth MuscleSpecificityTGF beta type III receptorTestingTherapeuticTissuesTransforming Growth FactorsUnited StatesVenouscell behaviorimmortalized cellimprovedin vitro testingin vivoinjuredinsightmeetingsnovelprogramsprotein expressionreceptorrepairedresearch studyvascular bedvasculogenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Coronary artery disease accounts for 54% of all cardiovascular disease in the United States [1]. Understanding how coronary vessels develop is likely to uncover novel drug targets and therapeutic strategies useful in directing the repair or remodeling of coronary vessels in adults. Recent data from our laboratory has demonstrated that targeted deletion of the Type III Transforming Growth Factor 2 receptor (TGF2R3) results in embryonic death associated with failure of the formation or persistence of the coronary vessels while other vascular beds appear to develop normally. Experiments are proposed to identify how the loss of TGF2R3 results in the failure of coronary vessel development and to reveal the TGF2 signaling pathways that regulate epicardial cell differentiation. We will test 3 specific hypotheses. Hypothesis 1: TGF2R3 is required for proper epicardial differentiation. This will be tested by in vivo analysis of the epicardium and epicardial derivatives in wildtype, heterozygous Tgfbr3 null, and homozygous Tgfbr3 null animals. Hypothesis 2: TGF2R3 is required in the epicardium or myocardium for proper coronary vessel development. This will be tested by conditional deletion of Tgfbr3 in the epicardium and myocardium. Hypothesis 3: Specific TGF2 signaling pathways regulate epicardial cell differentiation. This will be tested in vitro in both explants and immortalized cells from wildtype, heterozygous Tgfbr3 null, and homozygous Tgfbr3 null animals The successful completion of the proposed experiments will yield significant insight into the role of Transforming Growth Factor 2 (TGF2) in coronary vessel development. The unique nature of the derivation of the coronary vessels and the significance of coronary vessel disease in humans makes the determination of the mechanisms behind TGF2R3 regulation of coronary vasculogenesis of high significance from both a basic science and clinical perspective.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vanderbilt Experimental Research Training Inclusion Community Engagement Skills (VERTICES)
-
批准号:10470962
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2020
-
负责人:Joey V. Barnett
-
依托单位:
Vanderbilt Experimental Research Training Inclusion Community Engagement Skills (VERTICES)
-
批准号:10267758
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2020
-
负责人:Joey V. Barnett
-
依托单位:
Vanderbilt Experimental Research Training Inclusion Community Engagement Skills (VERTICES)
-
批准号:10685263
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2020
-
负责人:Joey V. Barnett
-
依托单位:
Promoting Academic Excellence through Community Engagement and Research Scholars Program (PAECER Scholars Program)
-
批准号:10545048
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2019
-
负责人:Joey V. Barnett
-
依托单位:
Promoting Academic Excellence through Community Engagement and Research Scholars Program (PAECER Scholars Program)
-
批准号:10337027
-
项目类别:
-
资助金额:$11.84万
-
财政年份:2019
-
负责人:Joey V. Barnett
-
依托单位:
Promoting Academic Excellence through Community Engagement and Research Scholars Program (PAECER Scholars Program)
-
批准号:10092825
-
项目类别:
-
资助金额:$8.73万
-
财政年份:2019
-
负责人:Joey V. Barnett
-
依托单位:
National Pharmacology Directors of Graduate Programs Meeting
-
批准号:8597091
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2014
-
负责人:Joey V. Barnett
-
依托单位:
National Pharmacology Directors of Graduate Programs Meeting
-
批准号:7675163
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2009
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7662025
-
项目类别:
-
资助金额:$2.96万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7919822
-
项目类别:
-
资助金额:$1.64万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7379859
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:8098399
-
项目类别:
-
资助金额:$2.79万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7556763
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7662024
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
National Pharmacology Directors of Graduate Programs Meeting
-
批准号:7277949
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2007
-
负责人:Joey V. Barnett
-
依托单位:
Training Program in Cardiovascular Pharmacology
-
批准号:7388269
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
Training Program in Cardiovascular Pharmacology
-
批准号:7214832
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
TGF beta and coronary vessel development
-
批准号:6893309
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
Core--Morphology and imaging
-
批准号:6893312
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
Training Program in Cardiovascular Pharmacology
-
批准号:7007679
-
项目类别:
-
资助金额:$25.16万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
海外基金